137.80CHF-3.77%Mkt Cap: 2.74B CHFP/E: 31.46Last update: 2026-06-01
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools f…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap2.74B CHF
Enterprise Value3.08B CHF
Revenue (TTM)683.83M CHF
Gross Profit458.66M CHF
Net Income (TTM)95.46M CHF
Revenue/Share34.32 CHF
Last Price137.80 CHF
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees2.0K
CountryCH
SectorHealthcare
IndustryMedical Devices
ISINCH0468525222
Valuation
P/E (Trailing)31.46
P/E (Forward)26.04
PEG—
EV/EBITDA17.93
EV/Revenue4.51
P/S4.17
P/B6.85
EPS (TTM)4.36
EPS (Forward)5.50
52W Range
128.0020% of range177.20
52W High177.20 CHF
52W Low128.00 CHF
Profitability
Gross Margin67.07%
Oper. Margin15.96%
EBITDA Margin25.13%
Profit Margin13.96%
ROE20.91%
ROA10.40%
Growth
Revenue Growth12.50%
Earnings Growth1.20%
Cash Flow & Leverage
Operating CF152.65M CHF
CapEx (TTM)143.10M CHF
FCF Margin-4.91%
FCF Yield-1.22%
Net Debt229.56M CHF
Net Debt/EBITDA1.34
Balance Sheet
Debt/Equity0.57
Current Ratio2.08
Quick Ratio0.77
Book Value/Sh20.90 CHF
Cash/Share1.668 CHF
Dividends
Fwd Div Rate1.100 CHF
Trail. Div Rate1.181 CHF
Div. Yield0.79%
5Y Avg Yield—
Payout Ratio15.48%
Ex-Div DateMay 7, 2026
Pay DateMay 13, 2025
Analyst Consensus
Rating—
Target (Mean)177.76 CHF
Target Range145.98 CHF – 198.31 CHF
# Analysts5
Ownership
Shares Out.19.91M
Float—
Insiders69.66%
Institutions18.31%
Technical
SMA 50147.33 (-6.5%)
SMA 200151.88 (-9.3%)
Beta1.00
S&P 52W Chg27.70%
Avg Vol (30d)15.47K
Avg Vol (10d)18.68K
Technical Indicators
RSI (14)48.3
MACD-1.5824
MACD Signal-2.3255
MACD Hist.+0.7430
BB Upper147.93 CHF
BB Middle141.01 CHF
BB Lower134.09 CHF
BB Width9.82%
ATR (14)4.328 CHF
Vol Ratio (20d)3.18x